$5.39
Price
$877M
Market Cap
29.9
P/E Ratio
6.3
Forward P/E
$0.18
EPS (TTM)
—
Dividend Yield
$140M
Cash
$599M
Total Debt
163M
Shares Out
$0.53
$5.78
52-Week Range
Institutional Ownership of IRONWOOD PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for IRONWOOD PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for IRONWOOD PHARMACEUTICALS INC
6 Months Insider Sentiment
Buy $0
Sell $183K
0
Buys
2
Sells
-183K
Net
2
Grants
Largest
$163K
Silver
$20K
Gaskins
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 05, 2026 | Ronald Silver | Principal Accounting Officer | SELL | 35.4K | $4.60 | $163K |
| Dec 15, 2025 | Alexander J Denner | Director, 10% Owner | GRANT | 4.2K | — | — |
| Nov 17, 2025 | Tammi L Gaskins | Chief Commercial Officer | SELL | 6.0K | $3.32 | $20K |
| Sep 15, 2025 | Alexander J Denner | Director, 10% Owner | GRANT | 11.7K | — | — |